Publications by authors named "Abeer Alzubaidi"

Claim this Profile
C
Coexistence of sickle cell disease and systemic lupus erythematosus is associated with quantitative and qualitative impairments in circulating regulatory B cells.
Mohamed-Rachid Boulassel, Amal Al-Naamani, Abeer Al-Zubaidi, Zahra Al-Qarni, Hammad Khan

Hum Immunol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNase HI Depletion Strongly Potentiates Cell Killing by Rifampicin in Mycobacteria.
Abeer Al-Zubaidi, Chen-Yi Cheung, Gregory M Cook, George Taiaroa, Valerie Mizrahi

Antimicrob Agents Chemother· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of intermittent and continuous proton pump inhibitor infusions in patients with non-variceal upper gastrointestinal bleeding at King Abdulaziz University Hospital, Jeddah, Saudi Arabia: A retrospective study.
Abeer S Alzubaidi, Ahmed F Basilim

Saudi Med J· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep Mining from Omics Data.
Abeer Alzubaidi, Jonathan Tepper

Methods Mol Biol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel deep mining model for effective knowledge discovery from omics data.
Abeer Alzubaidi, Jonathan Tepper, Ahmad Lotfi

Artif Intell Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated levels of circulating invariant natural killer cell subsets are skewed toward Th2-like phenotype in children with sickle cell disease.
Mohamed-Rachid Boulassel, Abeer Al-Zubaidi, Shoaib Al-Zadjali, Zahra Al-Qarni, Nidaa Al-Naamany

Clin Immunol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levels of regulatory T cells and invariant natural killer cells and their associations with regulatory B cells in patients with non-Hodgkin lymphoma.
Mohamed-Rachid Boulassel, Zahra Al Qarni, Ikram Burney, Hammad Khan, Abeer Al-Zubaidi

Mol Clin Oncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis